APA (7th ed.) Citation

Chan, A. T. C., Lee, V. H. F., Hong, R., Ahn, M., Chong, W. Q., Spreafico, A., . . . Siu, L. L. (2026). Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122. Cancer Medicine, 15(2), 1. https://doi.org/10.1002/cam4.71496

Chicago Style (17th ed.) Citation

Chan, Anthony T. C., et al. "Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122." Cancer Medicine 15, no. 2 (2026): 1. https://doi.org/10.1002/cam4.71496.

MLA (9th ed.) Citation

Chan, Anthony T. C., et al. "Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE‐122." Cancer Medicine, vol. 15, no. 2, 2026, p. 1, https://doi.org/10.1002/cam4.71496.